Global Antimicrobial Peptides Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 5.00 Billion |
 Market Size (Forecast Year) |
USD 7.85 Billion |
 CAGR |
% |
| Major Markets Players |
全球抗菌肽市场，副产品（植物抗菌肽、细菌抗菌肽、动物抗菌肽、昆虫抗菌肽）、疾病（肺炎、肝炎、细菌感染、艾滋病毒）、分销渠道（医院、研究机构、专科诊所、药房）、给药途径（局部、皮下、静脉注射）、最终用户（制药和医疗保健、农业产业、生物工程）——行业趋势和预测到 2029 年
市场分析和规模
据美国疾病控制与预防中心报道，2013 年报告的健康问题超过 200 万例，其中 23,000 人死于耐药性细菌。2012 年，美国报告了超过 450,000 例耐多药结核病新病例。全球耐药患者数量的不断增加，迫使人们开发新型抗生素来对抗常见的传染病。催产素、环孢菌素、鲑鱼降钙素、Integrillin 和 Zoladex 等肽类药物广为人知，并引领全球肽类疗法业务走向新方向。
Data Bridge Market Research 分析认为，抗菌肽市场规模在 2021 年为 50 亿美元，到 2029 年将飙升至 78.5 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 5.80%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（植物抗菌肽、细菌抗菌肽、动物抗菌肽、昆虫抗菌肽）、疾病（肺炎、肝炎、细菌感染、艾滋病毒）、分销渠道（医院、研究机构、专科诊所、药房）、给药途径（局部、皮下、静脉）、最终用户（制药和医疗保健、农业产业、生物工程） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Eli Lilly and Company (U.S), Pfizer Inc. (U.S), GSK Group of Companies (U.S), Novartis AG (Switzerland), EnBiotix Inc. (U.S), Johnson & Johnson Private Limited (U.S), Merck & Co., Inc. (U.S), Alexion Pharmaceuticals, Inc. (U.S), Melinta Therapeutics, LLC (U.S), Vertex Pharmaceuticals Incorporated (U.S) AnaSpec (U.S), AMP Biotech (India), Phoenix Biotechnology Inc. (Canada), Novabiotics (U.K), Chinese Peptide Company (China), Ontores Biotechnologies Inc. (China) |
|
Market Opportunities |
|
Market Definition
Antimicrobial peptides are compounds that are part of the host defence mechanism in both prokaryotic and eukaryotic cells, defending them from dangerous infective threats such as bacteria, viruses, and even fungi. Antimicrobial peptides is very dependent on their composition, and they are used to target cytoplasmic membranes, cell walls, DNA, and proteins.
Antimicrobial Peptides Market Dynamics
Drivers
- Technological advancements
With a growing pool of scientists and talented technocrats interested in the arena for innovative therapeutics containing antimicrobial peptides for rare diseases, institutional research is substantially invested. Antimicrobial peptides, for example, can be created for a variety of purposes ranging from extending the shelf life of food packaging to delivering bioactive substances in therapeutic sectors driving the market.
- Rise in infectious diseases
The rising frequency of infectious diseases and the rising demand for effective and safe medicines are driving the expansion of the antimicrobial peptides market. Furthermore, the use of AMPs in a variety of applications is likely to fuel market expansion throughout the forecast period.
- Usage of antimicrobial peptides
Antimicrobial peptides are gaining popularity as therapeutic agents for a variety of ailments, including skin infections. Antimicrobial peptides are a promising newcomer in the field of immune modulation and antifungal drugs. Anti-microbial peptides aid in the improvement of anti-inflammatory cell responses and have the ability to breakdown malignant cell membranes, making them a possible cancer treatment medicine. Anti-microbial peptides market is expected to develop in the near future due to rising demand for cancer, HIV, and diabetes therapy.
Opportunities
When compared to the hazards that exist, the prospects for producing antimicrobial peptides are greater. Antimicrobial peptides' use in the treatment of Hepatitis C, pneumonia, bacterial infections, HIV AIDS, and cancer is likely to increase public acceptability of the treatments. Due to increased awareness to medications and therapies incorporating antimicrobial peptides, the global market for antimicrobial peptides is expected to rise significantly. Chronic disorders where antibiotic resistance is ineffective give a more attractive opportunity for antimicrobial peptides manufacturers.
Restraints/Challenges
Furthermore, antimicrobial peptides are now undergoing clinical trials, and the stability and half-life of antimicrobial peptides in vivo are unknown. These issues are limiting the global growth of the antimicrobial peptides market.
This antimicrobial peptides market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antimicrobial peptides market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 impact on Antimicrobial Peptides Market
在所有国家，COVID-19 大流行都构成了重大的公共卫生威胁。人们仍在探索严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 感染对未来全球健康的影响，尤其是大流行对全球抗生素耐药性 (AMR) 的出现和传播的可能影响。病情危重的 COVID-19 患者可能会出现严重问题，使他们容易感染院内细菌和/或真菌病原体，从而需要使用抗生素。另一方面，在较轻的 COVID-19 感染病例中，抗生素可能会被误用。对杀菌剂使用增加、抗菌药物管理/感染控制、抗菌药物耐药性 (AMR) 意识、诊断需求（包括快速和即时诊断）以及疫苗接种效果的担忧都可能在确定 COVID-19 大流行的影响方面发挥作用。
全球抗菌肽 市场范围
抗菌肽市场根据产品类型、疾病、分销渠道、给药途径、应用和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 植物抗菌肽
- 细菌抗菌肽
- 动物抗菌肽
- 昆虫抗菌肽
疾病
- 肺炎
- 肝炎
- 细菌感染
- 艾滋病病毒
分销渠道
- 医院
- 研究机构
- 专科诊所
- 药店
给药途径
- 主题
- 皮下
- 静脉
终端用户
- 制药和医疗保健
- 农业产业
- 生物工程
抗菌肽 市场区域分析/见解
对抗菌肽市场进行了分析，并按国家、产品类型、应用和最终用户提供了市场规模见解和趋势，如上所述。
抗菌肽市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美由于先进或新兴的医疗保健环境而占据市场主导地位，有助于恢复市场并扩大对更广泛有需要的患者的影响。
预计亚太地区将成为 2022-2029 年预测期内增长最快的市场。这一增长可归因于该地区人口的增长、收入水平的提高以及医疗保健基础设施的扩大。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和抗菌肽 市场份额分析
抗菌肽市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对抗菌肽市场的关注有关。
抗菌肽市场的一些主要参与者包括：
- 礼来公司 (美国)
- 辉瑞公司（美国）
- 葛兰素史克集团（美国）
- 诺华公司（瑞士）
- EnBiotix Inc.（美国）
- 强生私人有限公司（美国）
- 默克公司（美国）
- Alexion Pharmaceuticals, Inc.（美国）
- Melinta Therapeutics, LLC（美国）
- Vertex Pharmaceuticals Incorporated（美国）
- AnaSpec (美国)
- AMP Biotech（印度）
- 菲尼克斯生物技术公司（加拿大）
- Novabiotics（英国）
- 中国多肽公司 (中国)
- 昂托雷斯生物科技有限公司（中国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
